Article
Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective study.
Thrombosis research - 15 Jul 2001
Nowak-Göttl U, Kotthoff S, Hagemeyer E, Junker R, Kehl H G, Vielhaber H, Kececioglu D
Abstract excerpt
UNLABELLED: To evaluate the role of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in children with an estimated risk of vascular occlusion reported to range from 7% to 16%, we conducted a prospective study in infants and children with underlying cardiac disease. One hundred and twenty-five children (neonate - 16 years) were investigated. In 9 infants out of the 125...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.